東京大学公共政策大学院 | GraSPP / Graduate School of Public Policy | The university of Tokyo

Registration is closed as we have reached our full capacity for the seminar.

MCDA Symposium

Open to public with simultaneous interpretation

Admission free

 

Date & Time      13：20－18：00  December 11, 2017

Venue                 Fukutake Hall, The University of Tokyo (map)

Sponsor              Health Policy & Technology Assessment Research Project, Graduate School of Public Policy,

                            The University of Tokyo

Cosponsor         ・The Canon Institute for Global Studies (CIGS)

                           ・European Federation of Pharmaceutical Industries and Associations (EFPIA)

                           ・Science, Technology, and Innovation Governance (STIG) Education Program, The University of Tokyo

                           ・Janssen Pharmaceutical K.K.

Auspice               Meiji Institute for Global Affairs (MIGA)

 

Preregistration is needed.  Please register from here.

Simultaneous interpretation available. Admission free.

 

Program

13:20-13:30         Opening remarks

                            ・Toshiaki Iizuka, Dean, Graduate School of Public Policy, The University of Tokyo

                            ・EFPIA Representative (TBD)

             

13:30-14:10     Lecture 1 “Introduction to MCDA: advantages and limitations for decision making in HTA” (tentative)

                            Rob Baltussen, Professor Global Health Economics

                            Radboud University Medical Center, the Netherlands

                            ISPOR MCDA Task Force member

 

14:10-14:50     Lecture 2 “MCDA in the Real World: case studies in Europe and North America” (tentative)

                            Dr.Vladimir Zah, ZRx Outcomes Research Inc., Canada

                            Chair, ISPOR Central & Eastern Europe Network

 

14:50-15:00      Break

 

15:00‐15:40       Lecture 3 “Potential Application of MCDA to New HTA policy in Japan”   

                             Isao Kamae, Project Professor, Graduate School of Public Policy, The University of Tokyo

                             Chair, ISPOR Asia Consortium Executive Committee

                             Member of Board of Directors, HTAi

 

15:40-16:20       Break

 

16:20-17:50       Panel Discussion

                          “Role and benefit of MCDA in Evidence-based Policy Making” 

                           Moderator            Hideaki Shiroyama, Professor, The University of Tokyo

                           Panelist                 Rob Baltussen

                                                         Vladimir Zah

                                                         Isao Kamae

                                                         MHLW officer (TBD)

                                                         Joerg Mahlich (Janssen Pharmaceuticals, Germany)

                                                                     

17:50-18:00     Closing Remark

                         Toshihiko Fukui, President, The Canon Institute for Global Studies